Loading patent…
AssigneeDermBiont, Inc.
InventorsRobert M. Brucker, Xuecheng Zhang, Ida Lister, Sanjay Jain
Estimating the term…
Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.
A pharmaceutical composition formulated for topical application comprising human-derived Janthinobacterium lividum comprising a nucleic acid sequence at least 95% identical to SEQ ID NO:
A method of treating, inhibiting or reducing a symptom of a disease, disorder or condition associated with a topical pathogenic microorganism in a human subject, comprising administering to the human subject a pharmaceutical composition formulated for topical application comprising an effective amount of human-derived Janthinobacterium lividum comprising a nucleic acid sequence at least 95% identical to SEQ ID NO:
A synthetic composition comprising human-derived Janthinobacterium lividum comprising a nucleic acid sequence 95% identical to SEQ ID NO:
Dependencies are inferred from the claim text.